Add Row
Add Element
cropper
update
[Company Name]
Concierge Health Hub logo
update
Add Element
  • Home
  • Categories
    • Practice Mastery
    • Patient Connect
    • Financial Fitness
    • Tech Advantage
    • Marketing Mastery
    • Regulatory Radar
    • Wellness Wisdom
May 15.2025
3 Minutes Read

Complement 1's New $16M Funding Paves the Way for Cancer Lifestyle Modification

 Complement 1's New $16M Funding Paves the Way for Cancer Lifestyle Modification


Revolutionizing Cancer Care Through Technology

In recent years, the demand for personalized health solutions has surged, particularly in cancer care, where lifestyle modification can significantly enhance patient outcomes. Complement 1 has emerged as a key player in this arena, having recently secured $16 million in seed funding to bolster its innovative cancer lifestyle modification platform. Founded in 2024, this health tech startup harnesses technology to offer personalized coaching that addresses the unique needs of cancer patients and those at high risk for the disease.

Understanding the Platform and Its Impact

At the heart of Complement 1's platform is a scientifically grounded approach that combines daily personalized guidance with support from dedicated CoActive Coaches. Each patient receives tailored interventions based on their cancer type, treatment stage, and personal preferences, enabling them to implement evidence-based lifestyle changes effectively. Early data from users indicates measurable improvements, including a remarkable 37% reduction in treatment side effects and a 27% enhancement in sleep quality. These figures are not just numbers—they reflect the profound impact that targeted lifestyle changes can have in complementing conventional therapies.

The Need for Integrative Care Models

Statistics reveal that nearly half of all Americans will face a cancer diagnosis in their lifetime, creating an urgent need for supportive healthcare models that integrate lifestyle medicine into treatment pathways. Despite the overwhelming evidence that lifestyle modifications can reduce cancer recurrence by as much as 35% and mortality rates by 37%, the integration of these practices in cancer treatment has been inconsistent. Complement 1 aims to fill this void, positioning itself as a vital resource for both patients and healthcare providers seeking to enhance care quality.

Funding Momentum and Future Developments

The recent $16 million funding round, led by Owl Ventures and Blume Ventures, represents a significant endorsement of Complement 1's potential. This investment will expedite the company’s plans to expand its coaching operations across the U.S., refine its AI-powered personalization engine, and strengthen collaborations with cancer centers and health plans. Such measures are crucial for scaling their impact and accessibility.

Engaging Patients Using Technology

Karan Bajaj, CEO and Co-Founder of Complement 1, emphasizes the necessity of bridging the gap between the understanding of lifestyle change benefits and their practical implementation in clinical settings. The platform’s high-touch coaching model is designed to engage patients actively, providing them with the motivation and accountability they need during their treatment journey. This ongoing support is fundamental to encouraging sustained lifestyle changes.

The Role of Concierge Health Practitioners

Concierge health practitioners are uniquely positioned to leverage platforms like Complement 1 in their practices, enhancing their service offerings amidst growing technological demands. By understanding the benefits of evidenced-based lifestyle interventions, these practitioners can more effectively guide their patients towards healthier lives, ultimately solidifying their standing within the community.

Next Steps for Practitioners

As the landscape of cancer care evolves, integrating technology such as Complement 1's platform into practice can provide significant value. Health practitioners should evaluate how lifestyle medicine can complement their patient management strategies and consider partnerships that enhance their offerings. Embracing these changes not only benefits patients but helps practitioners navigate the complexities of modern healthcare.

Conclusion: A Call to Action for Health Practitioners

As you consider integrating innovative solutions into your practice, staying informed about platforms like Complement 1 can help you remain competitive and effective in patient care. The need for lifestyle modifications in oncology is paramount. Don’t let unfamiliarity with technology hold you back—explore how you can implement these solutions for the benefit of your patients today! Understanding and utilizing digital platforms could be the key to transforming your practice and better serving your community.


Tech Advantage

Write A Comment

*
*
Related Posts All Posts
05.30.2025

The Future of Liver Health: Discovering the Periportal Assembloid Model

Update Revolutionizing Liver Disease Research: A Groundbreaking Model In the vast realm of medical research, the liver poses a significant challenge due to its intricate structure and the vital functions it performs. The recent development of an innovative model known as the "periportal assembloid" marks a pivotal advancement in our understanding of liver disease, particularly cholestatic liver injury and biliary fibrosis. This model creates an authentic representation of the liver's periportal region, where bile transport is initiated—a crucial area often compromised in various liver diseases. Historical Context: The Challenge of Liver Models For years, researchers struggled to replicate the liver's complex architecture in laboratory settings. Traditional models, primarily focusing on single cell types, lacked the necessary cellular interactions and structural integrity observed in the human liver. As a result, the study of liver diseases was severely limited, hindering progress in developing effective treatments. The groundwork for today's revolutionary periportal assembloid began in 2021, when the team from the Max Planck Institute, led by Meritxell Huch, first explored dual-cell organoid models. Significance of the Periportal Assembloid The periportal assembloid integrates crucial cell types—adult cholangiocytes, liver mesenchymal cells, and the pivotal hepatocytes—into a cohesive model. This multi-cellular approach not only allows for accurate modeling of the periportal architecture but also simulates how liver diseases like cholestasis develop. Notably, hepatocytes, the predominant liver cells responsible for key functions such as detoxification and bile production, play a vital role in the organoid's functionality. Practical Insights: What This Means for Health Practitioners For concierge health practitioners keen on staying ahead, understanding this model is essential. With liver diseases being a major concern for many patients, the ability to replicate liver pathology in a lab setting means faster and more efficient testing for potential therapies. Furthermore, insights derived from the periportal assembloid could lead to personalized medicine approaches, allowing practitioners to tailor treatments based on individual liver conditions. Future Predictions: The Path Forward Looking ahead, the implications of the periportal assembloid extend beyond liver disease research. As methodologies for constructing organoids improve, we may see the development of even more complex tissue models that can replicate other organs. This could revolutionize drug testing and disease understanding across various fields in medicine. Counterarguments: The Limitations of Models While models like the periportal assembloid represent substantial progress, it is important to acknowledge their limitations. Although they mimic some aspects of liver architecture and function, they cannot fully capture the dynamic interactions and environmental influences present in vivo. Researchers must continue to work toward refining these models to include more variables and complexities present in the human body. Actionable Insights: Engage and Advise Your Patients For health practitioners, it is vital to stay informed about these advancements. Engaging with patients about the latest research can empower them with knowledge about the potential for innovative therapies. Additionally, practices can leverage these insights by evaluating how they might incorporate research into their treatment protocols and patient care strategies. Conclusion: Embracing the Future of Liver Health The emergence of the periportal assembloid not only signifies a leap forward in liver disease research but also emphasizes the importance of interdisciplinary collaboration in scientific inquiry. By bridging technology with medicine, practitioners can look forward to enhanced treatment options in the future. It is essential for health professionals to stay abreast of such developments to ultimately provide the best care for their patients.

05.30.2025

Discover How Electronic Face Tattoos Gauge Mental Strain for Optimal Health

Update Revolutionizing Mental Health Monitoring with E-Tattoos The recent introduction of electronic face tattoos that measure mental strain opens up remarkable prospects in the realm of healthcare technology. Developed by researchers from the University of Texas at Austin, this innovative device is designed to provide real-time insights into cognitive load, thus helping to prevent critical lapses in concentration among professionals operating in high-stakes environments, such as air traffic controllers and truck drivers. Understanding Mental Load and Cognitive Performance Every individual experiences a unique peak mental workload where performance is optimized; however, discerning this "Goldilocks zone" can be challenging. As stated by study author Nanshu Lu, "Technology is developing faster than human evolution. Our brain capacity cannot keep up and can easily get overloaded." Assessing cognitive load has traditionally been subjective and tedious, relying on lengthy surveys like the NASA Task Load Index. In contrast, the e-tattoo offers an objective, streamlined solution by directly analyzing brainwave activity and eye movement without cumbersome headgear. The Technology Behind the E-Tattoo The e-tattoo comprises light, skin-friendly sensors that utilize electroencephalography (EEG) and electrooculography (EOG) to capture data. Unlike EEG caps known for their bulky structure and associated discomfort, this device is flexible and conforms to the user's facial features for optimal signal clarity. Each tattoo is custom-made to ensure that sensors maintain accurate positioning, resulting in more consistent signal capture compared to traditional methods, which often struggle due to varying head shapes. Insights from Research Testing In initial trials, six participants engaged in a progressively challenging memory task while wearing the e-tattoo. The outcomes were telling: as cognitive load increased, there was a corresponding rise in theta and delta brainwave activity, which indicated heightened mental effort, alongside a decrease in alpha and beta activity signalling fatigue. These findings imply that the device not only tracks current mental strain but also has the potential to predict future fatigue, adding a layer of proactive management to mental health monitoring. Benefits of Accessibility and Cost-Effectiveness This electronic tattoo comes with a significantly lower price tag compared to traditional EEG technology, which often exceeds $15,000. The e-tattoo's components, including chips and a battery pack, will cost around $200, while individual sensors are priced at about $20. This affordability could dramatically increase accessibility for healthcare settings, making it feasible for practitioners to integrate cognitive monitoring directly into routine care. Transforming Patient Care – A Must Know for Health Practitioners For concierge health practitioners keen on staying ahead of medical technology trends, adapting to tools like the e-tattoo could enhance patient engagement and outcomes. In a world where mental health issues are increasingly scrutinized, having real-time data can empower practitioners to adjust care based on individual needs, ensuring optimal cognitive health in their patients. Future Implications of E-Tattoo Technology As this technology develops, there is potential for broader applications beyond monitoring workload. Integrating mental load assessments into treatment plans could refine approaches to cognitive behavioral therapy and stress management strategies. Furthermore, the use of e-tattoos might extend to occupational health assessments in various work environments, where mental vigilance is paramount. Call to Action: Elevate Your Practice with E-Tattoo Insights As a concierge health practitioner, aligning your practice with the latest innovations, such as the electronic e-tattoo, can substantially improve your ability to monitor and respond to patients' mental health needs dynamically. Stay informed, be proactive, and explore how such advancements might redefine your approach to patient care.

05.30.2025

Revolutionary MERLIN Sensors Set to Transform Wound Care Monitoring

Discover how real-time sensors are revolutionizing wound care monitoring through nitric oxide quantification to enhance patient outcomes.

Add Row
Add Element
cropper
update
MYBRANDINGLOGO
Concierge Health Hub logo
update

Concierge Health Hub is a popular free resource for concierge medical practices in the English-speaking world, providing insights into everything from connecting with your patients, to marketing, to regulatory rules.

  • Concierge Health Hub Facebook Page URL
    update
  • update
  • update
  • update
  • update
  • update
  • update
Add Element

NEED TO CONTACT US?

If you have any enquiries, contact us now and we will get back to you as soon as possible.

Setup Your Button

   CONTACT US   

{"name":"Contact Us","action_type":"2","optin_action_type":"5","form_redirect_type":"2","form_redirect_custom_url":"","order_form_settings":{"containers":[{"id":"personal-info-wrapper","visible":true,"label":{"id":"of-personal-title","visible":true},"fields":[{"id":"of-full-name","setting":false,"placeholder":"Full Name"},{"id":"of-field-email","setting":false,"placeholder":"Email Address"},{"id":"of-phone-number","setting":true,"visible":false,"require":true,"placeholder":"Enter Your Mobile Phone","additional":{"sms_permission":0}},{"id":"of-gdpr-optin-approval","label":"I Accept To Receive Additional Info","placeholder":"","icon":"fa-mobile","required":0,"visible":0,"system":1,"additional":{"gdpr_optin_approval":"1"}}]},{"id":"shipping-information-wrapper","visible":false,"label":{"id":"of-shipping-title","visible":true},"fields":[{"id":"of-shipping-address","setting":false,"placeholder":"Address"},{"id":"of-shipping-city","setting":false,"placeholder":"City"},{"id":"of-shipping-state","setting":false,"placeholder":"State"},{"id":"of-shipping-zipcode","setting":false,"placeholder":"Postal Code"}]},{"id":"profit-bump-wrapper","visible":true,"otoBgColor":"rgba(219,229,239,1)","otoBorderColor":"rgba(38,71,102,1)","otoTitleBgColor":"rgba(45,78,108,1)","otoArrowsColor":"rgba(255,177,58,1)","fields":[]},{"id":"order-summary-wrapper","visible":true,"orderDynamicBgColor":"rgba(242,242,242,1)","orderDynamicTexColor":"rgba(51,51,51,1)","fields":[]}]},"optin_type":{"showLabels":0,"fields":[{"name":"first_name","label":"Full Name","placeholder":"Enter Your Full Name","icon":"fa-user","required":1,"visible":1,"system":1,"additional":{}},{"name":"last_name","label":"Full Name","placeholder":"Enter Your Full Name","icon":"fa-user","required":1,"visible":1,"system":1,"additional":{}},{"name":"email","label":"Email","placeholder":"Enter Your Email","icon":"fa-envelope","required":1,"visible":1,"system":1,"additional":{}},{"name":"mobile_phone","label":"Mobile Phone","placeholder":"Enter Your Mobile Phone","icon":"fa-mobile","required":0,"visible":0,"system":1,"additional":{"sms_permission":0}},{"name":"fields_labels","label":"","placeholder":"","icon":"","required":0,"visible":1,"system":1,"additional":{}},{"name":"captcha","label":"Captcha","placeholder":"","icon":"","required":1,"visible":1,"system":1,"additional":{}},{"name":"gdpr_optin_approval","label":"SSBBY2NlcHQgVG8gUmVjZWl2ZSBBZGRpdGlvbmFsIEluZm8=","placeholder":"","icon":"fa-mobile","required":0,"visible":1,"system":1,"additional":{"gdpr_optin_approval":"1","sms_permission":0}}],"customFields":[],"sortedFields":[{"name":"first_name","label":"Full Name","placeholder":"Enter Your Full Name","icon":"fa-user","required":1,"visible":1,"system":1,"additional":{}},{"name":"first_name","label":"Full Name","placeholder":"Enter Your Full Name","icon":"fa-user","required":1,"visible":1,"system":1,"additional":{}},{"name":"last_name","label":"Full Name","placeholder":"Enter Your Full Name","icon":"fa-user","required":1,"visible":1,"system":1,"additional":{}},{"name":"email","label":"Email","placeholder":"Enter Your Email","icon":"fa-envelope","required":1,"visible":1,"system":1,"additional":{}},{"name":"mobile_phone","label":"Mobile Phone","placeholder":"Enter Your Mobile Phone","icon":"fa-mobile","required":0,"visible":0,"system":1,"additional":{"sms_permission":0}},{"name":"captcha","label":"Captcha","placeholder":"","icon":"","required":1,"visible":1,"system":1,"additional":{}}],"design":{"form_background_color":"rgb(245, 245, 245)","field_stroke":{"size":"1","color":"rgb(220, 220, 220)"},"field_icons":1,"button_color":"rgb(255, 158, 0)","button_stroke":{"size":"0","color":"rgba(255, 255, 255, 0.2)"},"button_box_shadow_color":"none","field_size":"small","label_size":"16","label_color":"rgb(0, 0, 0)","input_color":"rgb(52, 152, 219)","control_text_color":"rgb(0, 0, 0)","control_text_size":"15"},"mappedFields":[]},"redirect_type":{"url":"","target":0},"next_step":{},"click_to_email":{"value":"info@banidadigital.com"},"click_to_call":{"value":""},"jump_to_block":{},"content":{"header_text":"PHNwYW4gc3R5bGU9ImZvbnQtc2l6ZToyNHB4OyBmb250LWZhbWlseTonb3BlbiBzYW5zJzsiPjxzcGFuIHN0eWxlPSJsaW5lLWhlaWdodDoxLjRlbTsiPldlIEFyZSBFeGNpdGVkITwvc3Bhbj48L3NwYW4+","content_text":"PHNwYW4gc3R5bGU9ImZvbnQtc2l6ZTo0OHB4OyBmb250LWZhbWlseTonb3BlbiBzYW5zJzsiPjxzcGFuIHN0eWxlPSJsaW5lLWhlaWdodDowLjllbTsiPjxzdHJvbmc+UExFQVNFIEZJTEwgT1VUIFlPVVIgSU5GTyAgQkVMT1cgVE8gU1VCU0NSSUJFPC9zdHJvbmc+PC9zcGFuPjwvc3Bhbj4=","button_text":"PHNwYW4gc3R5bGU9ImZvbnQtc2l6ZToyN3B4OyBmb250LWZhbWlseTonb3BlbiBzYW5zJzsiPjxzcGFuIHN0eWxlPSJsaW5lLWhlaWdodDoxZW07Ij48c3Ryb25nPlNFQ1VSRSBNWSBTUE9UPC9zdHJvbmc+PC9zcGFuPjwvc3Bhbj4=","spam_text":"PHNwYW4gc3R5bGU9ImxpbmUtaGVpZ2h0OjEuMmVtOyI+V2UgaGF0ZSBTUEFNIGFuZCBwcm9taXNlIHRvIGtlZXAgeW91ciBlbWFpbCBhZGRyZXNzIHNhZmU8L3NwYW4+","sms_text":"UmVjZWl2ZSBTTVMgVGV4dCBVcGRhdGVzIC0gPHNwYW4+b3B0aW9uYWw8L3NwYW4+","sms_text2":"SSBBY2NlcHQgVG8gUmVjZWl2ZSBBZGRpdGlvbmFsIEluZm8="},"email_confirmation":{"enable":1,"subject":"V2UgQXJlIEV4Y2l0ZWQhIFlvdXIgSW4h","message":""},"integrations":[],"automation_enable":0,"thank_you":{"type":"popup","redirect_url":"","popup_options":{"background_color":"#ffffff","headline_visible":1,"icon_visible":1,"icon_url":"//my.funnelpages.com/assets-pb/images/thankyou-popup-icon.png","subheadline_visible":1,"button_visible":1,"button_color":"#ffa800","headline_text":"PHNwYW4gc3R5bGU9ImxpbmUtaGVpZ2h0OjEuNGVtOyI+VGhhbmsgWW91IEZvciBDb250YWN0aW5nIFVzPC9zcGFuPg==","subeadline_text":"PHNwYW4gc3R5bGU9ImxpbmUtaGVpZ2h0OjEuNGVtOyI+UGxlYXNlIENoZWNrIFlvdXIgRW1haWw8YnIgLz5XZSBXaWxsIEJlIEZvbGxvd2luZyBVcCBTaG9ydGx5PC9zcGFuPg==","button_text":"Q2xvc2U="}}}
Add Element

© 2025 Alicorn Ventures, LLC All Rights Reserved. 30 N. Gould Ste R, Sheridan, WY 82801 . Contact Us . Terms of Service . Privacy Policy

{"company":"Alicorn Ventures, LLC","address":"30 N. Gould Ste R","city":"Sheridan","state":"WY","zip":"82801","email":"info@banidadigital.com","tos":"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","privacy":"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"}

Terms of Service

Privacy Policy

Core Modal Title

Sorry, no results found

You Might Find These Articles Interesting

T
Please Check Your Email
We Will Be Following Up Shortly
*
*
*